Fairvalue-Calculator Fairvalue-Calculator
EN DE

Valterra Platinum Limited (AGPPF) Fair Value & Analysis

Basic Materials · US · Market cap $21.4B

Price$71.38
Fair Value$83.33
Upside+16.7%
Quality95/100
Evidence: High Range $45.06 – $122.77

Analysis

Valterra Platinum Limited (AGPPF) currently trades at $71.38, while our model-based Fair Value estimate is $83.33 — implying the stock looks roughly 16.7% undervalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Valterra Platinum Limited engages in the production and supply of platinum group metals, base metals, and precious metals in South Africa, Asia, Europe, North America, and internationally. The company produces platinum, palladium, rhodium, ruthenium, iridium, and osmium; and nickel, copper, cobalt sulphate, and chrome, as well as gold and sodium sulphate. It also provides fuel cell electric vehicles. The company was formerly known as Anglo American Platinum Limited and changed its name to Valterra Platinum Limited in May 2025. The company was incorporated in 1946 and is headquartered in Johannesburg, South Africa.

Open the full interactive analysis →

Similar stocks

Fresnillo plc (FRES) -25% Hecla Mining Company (HCL) -33% Impala Platinum Holdings (IMPUY) -87% Northam Platinum Holdings (NPTLF) -85% Compañía de Minas Buenaventura S.A. (BVN) -3% Sibanye Stillwater Limited (SBYSF) +139%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.